Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

Autor: Topp, M.S., Gökbuget, N., Zugmaier, G., Stein, A.S., Dombret, H., Chen, Y., Ribera, Jose-Maria, Bargou, R.C., Horst, H.A., Kantarjian, H.M., Universitat Autònoma de Barcelona

Publikováno v: Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat. Dipósit de la Recerca de Catalunya

Background Blinatumomab is a CD19 BiTE (bispecific T‐cell engager) immuno‐oncology therapy that mediates the lysis of cells expressing CD19. Methods A pooled analysis of long‐term follow‐up data from 2 phase 2 studies that evaluated blinatumo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2299b086701da6aee0af5eb5a2f734
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3849

Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia

Autor: Gokbuget, N, Dombret, H, Giebel, S, Bruggemann, M, Doubek, M, Foa, R, Hoelzer, D, Kim, C, Martinelli, G, Parovichnikova, E, Ribera, JM, Schoonen, M, Tuglus, C, Zugmaier, G, Bassan, R

Publikováno v: European Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Objectives Survival outcomes from a single-arm phase 2 blinatumomab study in patients with minimal residual disease (MRD)-positive B-cell precursor (BCP)-acute lymphoblastic leukaemia (ALL) were compared with those receiving standard of care (SOC) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::406d652adbd015785d36c0339a7d15b3
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4223

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients

Autor: Aigner, A. ^*, Brachmann, P., Beyer, J., Jäger, R., Raulais, D., Vigny, M., Neubauer, A., Heidenreich, A., Weinknecht, S., Czubayko, F., Zugmaier, G.

Publikováno v: In Annals of Oncology October 2003 14(10):1525-1529